(Hypertension. 1997;29:268.)
© 1997 American Heart Association, Inc.
Arthur C. Corcoran Memorial Lecture |
Endogenous Estrogen and Acetylcholine-Induced Vasodilation in Normotensive Women
From I Clinica Medica (S.P., A.V., L.G., G.B., S.T., A.S.) and the Department of Obstetrics and Gynaecology (M.L., A.R.G.), University of Pisa; and the Department of Obstetrics and Gynaecology, University of Modena (F.P.), Italy.
Correspondence to Stefania Pinto, MD, I Clinica Medica, University of Pisa, Via Roma, 67, 56100 Pisa, Italy
Acute exogenous estrogen administration enhances endothelial function in postmenopausal women. To evaluate the effect of endogenous estrogen on endothelium-dependent vasodilation, in 10 fertile normotensive women (age range 45 to 51 years) we studied the changes in forearm blood flow (strain-gauge plethysmography) induced by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, 15 µg·100 mL-1·min-1), an endothelium-dependent vasodilator, or sodium nitroprusside (1, 2, 4 µg·100 mL-1·min-1), an endothelium-independent vasodilator, in basal conditions and within 1 month after ovariectomy. As control subjects, 10 matched healthy women were also evaluated. In basal condition, vasodilation to acetylcholine and sodium nitroprusside was similar in patients and control subjects. Ovariectomy was followed by endogenous estrogen deprivation (from 71.6±31.3 to <12 pg/mL) and was associated with a significant (P<.01) reduction in acetylcholine-induced vasodilation compared with baseline (maximum percent increase in forearm blood flow: baseline 568.2±47.1%; ovariectomy 309.5±37.4%); the response to sodium nitroprusside was unaffected by ovariectomy (maximum percent increase in forearm blood flow: baseline 526.4±36.5%; ovariectomy 454.7± 47.2%; P=NS). In 6 of 10 patients, the study was repeated after 3 months of estrogen replacement therapy (17ß-estradiol, 50 µg/d by transdermal patches). Exogenous estrogen restored acetylcholine-induced vasodilation (maximum percent increase in forearm blood flow: 548.9±43.1%; P<.01 versus ovariectomy), which was no longer different from baseline, whereas the response to sodium nitroprusside was not affected (maximum percent increase in forearm blood flow: 480.2±39.3%; P=NS). These results suggest a protective role of endogenous estrogen on endothelium-dependent vasodilation in the forearm vascular bed of normotensive women.
Key Words: endothelium • acetylcholine • estrogen • sodium nitroprusside
Abbreviations: CVD = cardiovascular disease • ERT = estrogen replacement therapy • FBF = forearm blood flow • LDL = low-density lipoprotein • NO = nitric oxide • NS = not significant
This article has been cited by other articles:
 |
|
 |
|
  V. Ricchiuti, C. G Lian, E. M Oestreicher, L. Tran, J. R Stone, T. Yao, E. W Seely, G. H Williams, and G. K Adler Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats J. Endocrinol., January 1, 2009; 200(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shibasaki, D. A. Low, S. L. Davis, and C. G. Crandall Nitric oxide inhibits cutaneous vasoconstriction to exogenous norepinephrine J Appl Physiol, November 1, 2008; 105(5): 1504 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Torgrimson, J. R. Meendering, P. F. Kaplan, and C. T. Minson Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2874 - H2880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J Pearson, C. Rait, M G. Nicholls, T. G Yandle, and J. J Evans Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. J. Endocrinol., October 1, 2006; 191(1): 171 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gimenez, M. P. Garcia, M. Serna, B. Bonacasa, L. F. Carbonell, T. Quesada, and I. Hernandez 17{beta}-Oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats Exp Physiol, July 1, 2006; 91(4): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V L Clifton, R Crompton, M A Read, P G Gibson, R Smith, and I M R Wright Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle J. Endocrinol., July 1, 2005; 186(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg Oral Contraceptives Improve Endothelial Function in Amenorrheic Athletes J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3162 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rogers and D. D. Sheriff Role of estrogen in nitric oxide- and prostaglandin-dependent modulation of vascular conductance during treadmill locomotion in rats J Appl Physiol, August 1, 2004; 97(2): 756 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Kalantaridou, K. K. Naka, E. Papanikolaou, N. Kazakos, M. Kravariti, K. A. Calis, E. A. Paraskevaidis, D. A. Sideris, A. Tsatsoulis, G. P. Chrousos, et al. Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3907 - 3913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Kirwan, N. J. MacLusky, H. M. Shapiro, B. L. Abramson, S. G. Thomas, and J. M. Goodman Acute and Chronic Effects of Hormone Replacement Therapy on the Cardiovascular System in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1618 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Chambliss and P. W. Shaul Estrogen Modulation of Endothelial Nitric Oxide Synthase Endocr. Rev., October 1, 2002; 23(5): 665 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.C. Duncan, J.R. Petrie, M.J. Brosnan, A.M. Devlin, R.A. Bass, D.S. Charnock-Jones, J.M.C. Connell, A.F. Dominiczak, and M.A. Lumsden Is estradiol cardioprotection a nitric oxide-mediated effect? Hum. Reprod., July 1, 2002; 17(7): 1918 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Herrington, M. A. Espeland, J. R. Crouse III, J. Robertson, W. A. Riley, M. A. McBurnie, and G. L. Burke Estrogen Replacement and Brachial Artery Flow-Mediated Vasodilation in Older Women Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1955 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Beyer, G. Yu, H. Hanke, and H. M. Hoffmeister Acute Gender-Specific Hemodynamic and Inotropic Effects of 17{beta}-Estradiol on Rats Hypertension, November 1, 2001; 38(5): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Chan, R. J. MacAllister, H. M. Colhoun, P. Vallance, and A. D. Hingorani Changes in Endothelium-Dependent Vasodilatation and {{alpha}}-Adrenergic Responses in Resistance Vessels during the Menstrual Cycle in Healthy Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2499 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Weitz, M. Elam, J. Born, H. L. Fehm, and C. Dodt Postmenopausal Estrogen Administration Suppresses Muscle Sympathetic Nerve Activity J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 344 - 348. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. O. Steinberg, G. Paradisi, J. Cronin, K. Crowde, A. Hempfling, G. Hook, and A. D. Baron Type II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women Circulation, May 2, 2000; 101(17): 2040 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Charkoudian, D. P. Stephens, K. C. Pirkle, W. A. Kosiba, and J. M. Johnson Influence of female reproductive hormones on local thermal control of skin blood flow J Appl Physiol, November 1, 1999; 87(5): 1719 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Case and C. A. Davison Estrogen Alters Relative Contributions of Nitric Oxide and Cyclooxygenase Products to Endothelium-Dependent Vasodilation J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 524 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
S. C. Lim, A. E. Caballero, S. Arora, P. Smakowski, E. M. Bashoff, F. M. Brown, F. W. Logerfo, E. S. Horton, and A. Veves The Effect of Hormonal Replacement Therapy on the Vascular Reactivity and Endothelial Function of Healthy Individuals and Individuals with Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4159 - 4164. [Abstract] [Full Text]
|
|
|
|
|
|
N. J. Brown, J. V. Gainer, C. M. Stein, and D. E. Vaughan Bradykinin Stimulates Tissue Plasminogen Activator Release in Human Vasculature Hypertension, June 1, 1999; 33(6): 1431 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Manau, J. Balasch, V. Arroyo, W. Jiménez, F. Fábregues, R. Casamitjana, M. Creus, and J. A. Vanrell Circulatory Dysfunction in Asymptomatic in Vitro Fertilization Patients. Relationship with Hyperestrogenemia and Activity of Endogenous Vasodilators J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1489 - 1493. [Abstract] [Full Text]
|
|
|
|
|
|
N. Charkoudian and J. M. Johnson Modification of active cutaneous vasodilation by oral contraceptive hormones J Appl Physiol, December 1, 1997; 83(6): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|